Tag: OCEANIC-STROKE
Investigational Factor XIa inhibitor achieves reduction in secondary ischaemic stroke
The investigational anti-clotting medication asundexian (Bayer) has demonstrated a reduction in the risk of a second ischaemic stroke without raising bleeding-related concerns, according to preliminary...
